Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Clinical Therapeutics|October 27, 2010
Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testingKay Stubenrauch, Uwe Wessels, Herbert Birnboeck, et al.Journal of the American Academy of Dermatology|February 21, 2006
Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trialGerald G Krueger, Boni Elewski, Kim Papp, et al.Journal of the American Academy of Dermatology|February 21, 2006
Efficacy of etanercept in an integrated multistudy database of patients with psoriasisKenneth Gordon, Neil Korman, Ellen Frankel, et al.Rheumatology and Therapy|November 18, 2019
Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims PopulationSara L Gale, Huong Trinh, Nitya Mathew, et al.Journal of the American Academy of Dermatology|October 26, 2005
Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trialSteven R Feldman, Alexa Boer Kimball, Gerald G Krueger, et al.Arthritis Research & Therapy|September 3, 2011
Integrated safety in tocilizumab clinical trialsMichael H Schiff, Joel M Kremer, Angelika Jahreis, et al.Archives of Dermatology|June 20, 2007
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasisStephen Tyring, Kenneth B Gordon, Yves Poulin, et al.The Journal of Dermatological Treatment|February 10, 2006
Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapyKenneth B Gordon, Alice B Gottlieb, Craig L Leonardi, et al.Arthritis Care & Research|October 9, 2018
Long-Term Safety of Rituximab in Rheumatoid Arthritis: Analysis From the SUNSTONE RegistryKevin L Winthrop, Kenneth Saag, Matthew D Cascino, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 3, 2018
Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic SclerosisGiuseppina Stifano, Thierry Sornasse, Lisa M Rice, et al.Pageof 3